Free Trial

ASGN (ASGN) Financials

ASGN logo
$53.62 -0.59 (-1.08%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$53.55 -0.08 (-0.14%)
As of 05/23/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for ASGN

Annual Income Statements for ASGN

This table shows ASGN's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
170 222 266 411 200 174 155 164 95 94
Consolidated Net Income / (Loss)
175 219 268 410 200 175 158 158 97 98
Net Income / (Loss) Continuing Operations
175 219 267 232 178 150 158 158 97 71
Total Pre-Tax Income
240 298 364 313 242 204 204 197 157 122
Total Operating Income
304 364 410 351 281 276 260 225 190 152
Total Gross Profit
1,184 1,280 1,370 1,142 947 972 1,024 850 795 679
Total Revenue
4,100 4,451 4,581 4,010 3,502 3,416 3,400 2,626 2,440 2,065
Operating Revenue
4,100 4,451 4,581 4,010 3,502 3,416 3,400 2,626 2,440 2,065
Total Cost of Revenue
2,916 3,171 3,212 2,867 2,555 2,444 2,376 1,776 1,645 1,386
Operating Cost of Revenue
2,916 3,171 3,212 2,867 2,555 2,444 2,376 1,776 1,645 1,386
Total Operating Expenses
879 916 960 792 666 695 764 625 605 527
Selling, General & Admin Expense
821 844 895 736 615 645 705 592 566 492
Amortization Expense
58 72 65 56 51 50 59 33 40 34
Total Other Income / (Expense), net
-64 -66 -46 -38 -40 -72 -56 -28 -32 -30
Interest Expense
64 66 46 38 40 72 56 28 32 30
Income Tax Expense
65 78 97 82 64 55 46 39 60 50
Net Income / (Loss) Discontinued Operations
0.00 0.00 1.20 178 23 25 -0.30 -0.20 0.01 26
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
5.00 -2.70 2.40 -0.70 - 0.70 2.70 -6.50 1.86 3.71
Basic Earnings per Share
$3.88 $4.54 $5.30 $7.78 $3.80 $3.31 $3.02 $3.01 $1.83 $3.74
Weighted Average Basic Shares Outstanding
45.20M 48.30M 50.60M 52.70M 52.70M 52.80M 52.30M 52.50M 53.19M 52.26M
Diluted Earnings per Share
$3.83 $4.50 $5.23 $7.66 $3.76 $3.28 $2.98 $2.97 $1.81 $3.68
Weighted Average Diluted Shares Outstanding
45.70M 48.70M 51.30M 53.50M 53.30M 53.40M 53.10M 53.20M 53.75M 53.01M
Weighted Average Basic & Diluted Shares Outstanding
43.60M 46.50M 49.30M 51.60M 53M 53M 52.66M 52.40M 53.10M 52.20M

Quarterly Income Statements for ASGN

This table shows ASGN's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
22 35 48 49 38 52 58 62 51 55 71
Consolidated Net Income / (Loss)
21 42 48 47 38 50 59 60 50 56 73
Net Income / (Loss) Continuing Operations
21 42 48 47 38 50 59 60 50 56 71
Total Pre-Tax Income
31 59 63 65 53 67 80 82 69 76 96
Total Operating Income
47 74 79 80 71 83 99 98 84 90 108
Total Gross Profit
275 286 300 301 296 305 322 326 326 340 359
Total Revenue
968 985 1,031 1,035 1,049 1,074 1,117 1,131 1,129 1,150 1,198
Operating Revenue
968 985 1,031 1,035 1,049 1,074 1,117 1,131 1,129 1,150 1,198
Total Cost of Revenue
693 699 731 734 753 769 794 805 802 810 839
Operating Cost of Revenue
693 699 731 734 753 769 794 805 802 810 839
Total Operating Expenses
229 212 222 221 225 222 224 228 242 250 251
Selling, General & Admin Expense
215 198 208 206 210 204 206 211 224 230 233
Amortization Expense
14 14 14 15 15 18 18 18 18 20 18
Total Other Income / (Expense), net
-15 -15 -16 -16 -18 -17 -19 -16 -15 -14 -12
Interest Expense
15 15 16 16 18 17 19 16 15 14 12
Income Tax Expense
10 17 15 17 15 16 21 22 19 20 25
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
-0.80 7.10 -0.20 -2.10 0.20 -1.60 1.30 -1.40 -1.00 - 2.20
Basic Earnings per Share
$0.48 $0.96 $1.07 $1.03 $0.82 $1.08 $1.23 $1.23 $1.00 ($0.34) $2.92
Weighted Average Basic Shares Outstanding
43.70M 45.20M 44.50M 45.70M 46.50M 48.30M 48.10M 49M 49.30M 50.60M 50.10M
Diluted Earnings per Share
$0.48 $0.94 $1.06 $1.02 $0.81 $1.06 $1.23 $1.22 $0.99 ($0.34) $2.88
Weighted Average Diluted Shares Outstanding
44M 45.70M 45M 46.10M 46.90M 48.70M 48.40M 49.20M 49.80M 51.30M 50.70M
Weighted Average Basic & Diluted Shares Outstanding
43.80M 43.60M 44.20M 44.80M 45.90M 46.50M 47.20M 48.40M 49.30M 49.30M 49.90M

Annual Cash Flow Statements for ASGN

This table details how cash moves in and out of ASGN's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
29 106 -459 255 179 53 5.10 9.60 3.18 -7.85
Net Cash From Operating Activities
400 457 308 194 425 313 287 196 199 124
Net Cash From Continuing Operating Activities
400 457 308 194 425 313 287 196 199 124
Net Income / (Loss) Continuing Operations
175 219 268 410 200 175 158 158 97 72
Consolidated Net Income / (Loss)
175 219 268 410 200 175 158 158 97 98
Depreciation Expense
96 100 91 90 90 91 95 59 62 52
Non-Cash Adjustments To Reconcile Net Income
51 54 58 -158 38 74 50 46 41 46
Changes in Operating Assets and Liabilities, net
77 83 -109 -148 97 -27 -15 -66 -1.49 -45
Net Cash From Investing Activities
-35 -41 -510 247 -219 -149 -789 -50 -22 -462
Net Cash From Continuing Investing Activities
-35 -41 -510 247 -219 -149 -789 -50 -22 -462
Purchase of Property, Plant & Equipment
-35 -40 -38 -35 -33 -33 -29 -24 -27 -25
Acquisitions
0.00 0.00 -485 -223 -186 -116 -760 -26 0.00 -553
Divestitures
0.00 0.00 9.80 504 0.00 0.00 - - 6.00 115
Other Investing Activities, net
0.00 -0.60 2.30 0.20 -0.20 0.00 0.20 0.10 -0.85 0.50
Net Cash From Financing Activities
-333 -311 -257 -184 -29 -111 508 -139 -174 331
Net Cash From Continuing Financing Activities
-333 -311 -257 -184 -29 -111 508 -139 -174 333
Repayment of Debt
-7.40 -610 -71 -1.40 -67 -744 -318 -108 -130 -540
Repurchase of Common Equity
-327 -273 -281 -181 -28 -20 0.00 -60 -41 -1.65
Issuance of Debt
0.00 572 94 0.00 66 653 822 37 11 875
Issuance of Common Equity
17 19 19 14 12 13 9.40 7.80 9.76 6.59
Other Financing Activities, net
-16 -18 -17 -16 -12 -12 -5.60 -15 -7.02 -6.65
Effect of Exchange Rate Changes
-2.20 0.10 -0.60 -0.60 2.40 -0.20 -1.40 1.80 -0.11 -1.47
Cash Interest Paid
63 62 44 35 38 45 51 24 27 22
Cash Income Taxes Paid
34 45 55 170 64 57 21 55 38 45

Quarterly Cash Flow Statements for ASGN

This table details how cash moves in and out of ASGN's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
-98 39 34 -26 -18 30 52 29 -5.30 -141 -279
Net Cash From Operating Activities
17 100 136 91 73 116 148 113 81 75 88
Net Cash From Continuing Operating Activities
17 100 136 91 73 116 148 113 81 75 88
Net Income / (Loss) Continuing Operations
21 42 48 47 38 50 59 60 50 56 73
Consolidated Net Income / (Loss)
21 42 48 47 38 50 59 60 50 56 73
Depreciation Expense
26 24 23 25 25 26 25 25 25 27 25
Non-Cash Adjustments To Reconcile Net Income
20 11 12 14 15 11 16 13 14 15 14
Changes in Operating Assets and Liabilities, net
-50 23 53 5.50 -4.10 29 47 14 -7.50 -22 -24
Net Cash From Investing Activities
-316 -11 -8.00 -5.20 -11 -7.20 -9.80 -11 -12 -143 -361
Net Cash From Continuing Investing Activities
-316 -11 -8.00 -5.20 -11 -7.20 -9.80 -11 -12 -143 -361
Purchase of Property, Plant & Equipment
-10 -11 -7.90 -5.30 -11 -7.20 -9.80 -11 -12 -11 -8.60
Acquisitions
-306 - - - - - - - - -133 -
Net Cash From Financing Activities
201 -50 -93 -111 -80 -79 -86 -73 -73 -73 -6.60
Net Cash From Continuing Financing Activities
201 -50 -93 -111 -80 -79 -86 -73 -73 -73 -6.60
Repayment of Debt
-16 -3.60 -1.30 -1.20 -1.30 -1.30 -499 -42 -68 -63 -
Repurchase of Common Equity
-50 -44 -96 -108 -80 -75 -91 -58 -49 -54 -60
Issuance of Debt
265 - - - 0.00 - 499 37 36 48 46
Issuance of Common Equity
8.70 - 7.70 - 9.50 - 7.80 - 11 - 8.50
Other Financing Activities, net
-5.80 -2.10 -3.70 -1.50 -8.50 -2.60 -1.50 -10 -4.20 -3.70 -1.60
Effect of Exchange Rate Changes
0.10 -0.70 -0.50 -1.00 0.00 0.40 -0.30 0.10 -0.10 - -0.40
Cash Interest Paid
9.10 21 9.60 22 9.80 23 9.30 22 8.60 20 5.20
Cash Income Taxes Paid
1.90 11 9.70 12 1.50 33 4.00 6.00 2.00 21 16

Annual Balance Sheets for ASGN

This table presents ASGN's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
3,429 3,545 3,586 3,503 3,278 2,941 2,688 1,810 1,753 1,767
Total Current Assets
918 973 981 1,309 994 792 686 500 438 414
Cash & Equivalents
205 176 70 530 274 95 42 37 - 24
Accounts Receivable
651 742 854 708 603 649 614 429 387 355
Prepaid Expenses
45 37 40 41 23 29 11 19 6.33 13
Other Current Assets
17 19 17 30 17 18 19 16 17 23
Plant, Property, & Equipment, net
83 81 66 55 55 74 79 58 57 53
Total Noncurrent Assets
2,429 2,490 2,538 2,138 2,229 2,076 1,922 1,253 1,258 1,300
Goodwill
1,893 1,894 1,892 1,570 1,421 1,487 1,421 894 874 875
Intangible Assets
440 498 570 488 470 477 489 353 378 418
Other Noncurrent Operating Assets
96 98 77 81 94 113 13 5.75 6.96 7.07
Total Liabilities & Shareholders' Equity
3,429 3,545 3,586 3,503 3,278 2,941 2,688 1,810 1,753 1,767
Total Liabilities
1,652 1,653 1,684 1,637 1,691 1,565 1,506 819 884 983
Total Current Liabilities
367 394 442 451 416 341 308 167 162 160
Accounts Payable
27 34 35 20 38 39 43 6.87 6.27 9.13
Current Employee Benefit Liabilities
218 237 285 306 239 203 212 130 127 103
Other Current Liabilities
122 124 122 125 100 99 50 29 28 47
Total Noncurrent Liabilities
1,285 1,258 1,243 1,187 1,275 1,224 1,198 652 721 822
Long-Term Debt
1,034 1,037 1,067 1,034 1,033 1,032 1,100 575 640 756
Noncurrent Deferred & Payable Income Tax Liabilities
188 156 129 89 109 99 80 69 74 62
Other Noncurrent Operating Liabilities
64 66 47 64 121 93 17 7.37 6.59 5.12
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,777 1,892 1,901 1,865 1,587 1,376 1,182 991 869 785
Total Preferred & Common Equity
1,777 1,892 1,901 1,865 1,587 1,376 1,182 991 869 785
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,777 1,892 1,901 1,865 1,587 1,376 1,182 991 869 785
Common Stock
685 697 704 691 662 639 602 567 563 543
Retained Earnings
1,097 1,196 1,200 1,174 926 745 586 428 316 250
Accumulated Other Comprehensive Income / (Loss)
-5.00 0.00 -2.70 -0.30 -1.00 -7.00 -6.30 -3.64 -10 -8.16

Quarterly Balance Sheets for ASGN

This table presents ASGN's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
3,698 3,432 3,451 3,489 3,579 3,561 3,525 3,611
Total Current Assets
880 907 914 933 994 972 927 1,120
Cash & Equivalents
107 167 132 158 146 94 65 211
Accounts Receivable
705 686 721 725 805 829 823 878
Prepaid Expenses
50 36 43 31 25 33 24 15
Other Current Assets
85 18 18 19 18 16 16 16
Plant, Property, & Equipment, net
80 79 79 83 79 76 72 62
Total Noncurrent Assets
2,799 2,445 2,458 2,473 2,506 2,513 2,527 2,429
Goodwill
2,140 1,894 1,894 1,894 1,894 1,894 1,894 1,806
Intangible Assets
504 454 468 483 516 534 552 545
Other Noncurrent Operating Assets
156 97 96 96 97 85 82 78
Total Liabilities & Shareholders' Equity
3,698 3,432 3,451 3,489 3,579 3,561 3,525 3,611
Total Liabilities
1,905 1,657 1,643 1,627 1,670 1,635 1,602 1,722
Total Current Liabilities
372 404 390 372 443 417 386 492
Accounts Payable
24 26 23 26 32 24 34 34
Current Employee Benefit Liabilities
211 237 233 233 251 267 252 329
Other Current Liabilities
180 141 134 113 160 126 100 130
Total Noncurrent Liabilities
1,578 1,254 1,253 1,256 1,227 1,218 1,216 1,230
Long-Term Debt
1,283 1,034 1,035 1,036 1,038 1,036 1,035 1,081
Capital Lease Obligations
45 - - - - - - -
Noncurrent Deferred & Payable Income Tax Liabilities
191 156 156 156 131 129 129 98
Other Noncurrent Operating Liabilities
60 63 61 63 59 53 51 51
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,793 1,774 1,808 1,861 1,909 1,927 1,924 1,889
Total Preferred & Common Equity
1,793 1,774 1,808 1,861 1,909 1,927 1,924 1,889
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,793 1,774 1,808 1,861 1,909 1,927 1,924 1,889
Common Stock
719 685 688 696 702 703 715 703
Retained Earnings
1,078 1,091 1,123 1,165 1,208 1,224 1,210 1,190
Accumulated Other Comprehensive Income / (Loss)
-4.20 -2.10 -2.30 -0.20 -1.60 -0.30 -1.70 -4.20

Annual Metrics And Ratios for ASGN

This table displays calculated financial ratios and metrics derived from ASGN's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
-7.88% -2.85% 14.26% 14.49% 2.53% 0.46% 29.47% 7.60% 18.18% 19.73%
EBITDA Growth
-13.72% -7.29% 13.71% 18.77% 0.95% 3.43% 25.38% 12.43% 23.64% 15.69%
EBIT Growth
-16.40% -11.09% 16.70% 24.79% 1.81% 6.15% 15.80% 18.43% 24.63% 10.42%
NOPAT Growth
-17.19% -10.77% 15.82% 25.50% 2.23% 0.47% 11.84% 53.65% 31.47% 10.05%
Net Income Growth
-20.11% -18.20% -34.59% 104.64% 14.65% 10.78% 0.00% 62.24% -0.46% 26.52%
EPS Growth
-14.89% -13.96% -31.72% 103.72% 14.63% 10.07% 0.34% 64.09% -50.82% 29.58%
Operating Cash Flow Growth
-12.45% 48.44% 58.91% -54.40% 35.63% 8.98% 46.33% -1.47% 60.69% 29.18%
Free Cash Flow Firm Growth
-10.43% 281.70% -553.86% -107.82% 242.90% 125.46% -484.99% -12.57% 130.75% -431.59%
Invested Capital Growth
-5.37% -5.00% 22.28% 14.18% -10.28% 3.24% 46.46% 3.22% -2.25% 62.16%
Revenue Q/Q Growth
-2.13% -1.69% 2.15% 7.46% 7.97% -10.78% 7.96% 2.27% 1.81% 7.08%
EBITDA Q/Q Growth
-2.67% -1.67% -0.12% 6.22% 5.73% -6.75% 6.74% 5.17% 1.20% 6.76%
EBIT Q/Q Growth
-2.93% -1.89% -1.23% 8.60% 7.00% -8.39% 5.62% 7.11% 1.60% 4.85%
NOPAT Q/Q Growth
-4.26% -1.21% -2.06% 9.24% 7.15% -9.06% -9.48% 35.63% 3.55% 3.36%
Net Income Q/Q Growth
-4.31% -2.36% -9.88% 7.78% 8.74% -3.64% -11.98% 37.88% 5.07% -1.15%
EPS Q/Q Growth
-3.04% 45.16% -26.96% 7.89% 8.67% -4.09% -11.83% 118.38% -36.49% -1.60%
Operating Cash Flow Q/Q Growth
-3.89% 9.88% 104.79% -46.62% 1.34% 5.95% 1.98% 0.92% 10.95% 7.53%
Free Cash Flow Firm Q/Q Growth
-5.25% 79.89% 13.67% -109.23% 288.39% -40.05% 0.83% 2.87% 21.37% -19.63%
Invested Capital Q/Q Growth
-1.41% -1.71% 5.04% 8.28% -10.84% 2.85% -0.11% 1.52% -1.37% 0.13%
Profitability Metrics
- - - - - - - - - -
Gross Margin
28.87% 28.76% 29.90% 28.49% 27.05% 28.44% 30.11% 32.37% 32.58% 32.87%
EBITDA Margin
9.77% 10.43% 10.93% 10.99% 10.59% 10.76% 10.45% 10.79% 10.33% 9.87%
Operating Margin
7.42% 8.18% 8.94% 8.75% 8.03% 8.09% 7.65% 8.56% 7.77% 7.37%
EBIT Margin
7.42% 8.18% 8.94% 8.75% 8.03% 8.09% 7.65% 8.56% 7.77% 7.37%
Profit (Net Income) Margin
4.27% 4.93% 5.85% 10.22% 5.72% 5.11% 4.64% 6.01% 3.98% 4.73%
Tax Burden Percent
72.97% 73.66% 73.73% 130.79% 82.94% 85.47% 77.23% 80.01% 61.75% 80.10%
Interest Burden Percent
78.88% 81.76% 88.79% 89.31% 85.88% 74.00% 78.48% 87.72% 82.96% 80.08%
Effective Tax Rate
27.03% 26.34% 26.60% 26.04% 26.46% 26.76% 22.62% 19.89% 38.25% 41.42%
Return on Invested Capital (ROIC)
8.29% 9.49% 11.41% 11.68% 9.42% 8.88% 10.68% 11.95% 7.81% 7.27%
ROIC Less NNEP Spread (ROIC-NNEP)
2.74% 4.23% 7.08% 41.97% 8.51% 6.12% 5.22% 8.08% 4.85% 8.92%
Return on Net Nonoperating Assets (RNNOA)
1.26% 2.07% 2.82% 12.07% 4.09% 4.77% 3.83% 5.00% 3.94% 6.49%
Return on Equity (ROE)
9.55% 11.56% 14.24% 23.75% 13.52% 13.66% 14.51% 16.95% 11.76% 13.76%
Cash Return on Invested Capital (CROIC)
13.81% 14.62% -8.63% -1.56% 20.27% 5.70% -27.02% 8.79% 10.09% -40.15%
Operating Return on Assets (OROA)
8.73% 10.21% 11.55% 10.35% 9.04% 9.81% 11.57% 12.61% 10.78% 10.08%
Return on Assets (ROA)
5.02% 6.15% 7.56% 12.09% 6.44% 6.21% 7.01% 8.85% 5.52% 6.47%
Return on Common Equity (ROCE)
9.55% 11.56% 14.24% 23.75% 13.52% 13.66% 14.51% 16.95% 11.76% 13.76%
Return on Equity Simple (ROE_SIMPLE)
9.86% 11.59% 14.10% 21.97% 12.62% 12.69% 13.34% 15.91% 11.19% 12.44%
Net Operating Profit after Tax (NOPAT)
222 268 301 260 207 202 201 180 117 89
NOPAT Margin
5.42% 6.03% 6.56% 6.47% 5.90% 5.92% 5.92% 6.85% 4.80% 4.32%
Net Nonoperating Expense Percent (NNEP)
5.56% 5.27% 4.33% -30.30% 0.91% 2.76% 5.46% 3.87% 2.97% -1.65%
Return On Investment Capital (ROIC_SIMPLE)
7.90% 9.16% 10.13% - - - - - - -
Cost of Revenue to Revenue
71.13% 71.24% 70.10% 71.51% 72.95% 71.56% 69.89% 67.63% 67.42% 67.13%
SG&A Expenses to Revenue
20.03% 18.97% 19.54% 18.35% 17.56% 18.88% 20.74% 22.54% 23.19% 23.83%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
21.45% 20.58% 20.96% 19.74% 19.02% 20.36% 22.46% 23.82% 24.81% 25.50%
Earnings before Interest and Taxes (EBIT)
304 364 410 351 281 276 260 225 190 152
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
401 464 501 441 371 367 355 283 252 204
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.07 2.40 2.14 3.45 2.78 2.72 2.42 3.37 2.69 3.02
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.90 1.02 0.89 1.60 1.26 1.10 0.84 1.27 0.96 1.15
Price to Earnings (P/E)
21.64 20.45 15.30 15.66 22.06 21.54 18.45 20.36 24.52 25.23
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
4.62% 4.89% 6.53% 6.39% 4.53% 4.64% 5.42% 4.91% 4.08% 3.96%
Enterprise Value to Invested Capital (EV/IC)
1.73 1.96 1.75 2.93 2.49 2.02 1.75 2.54 1.99 2.05
Enterprise Value to Revenue (EV/Rev)
1.10 1.21 1.11 1.73 1.48 1.37 1.15 1.48 1.21 1.50
Enterprise Value to EBITDA (EV/EBITDA)
11.26 11.63 10.11 15.74 13.96 12.75 11.03 13.70 11.71 15.24
Enterprise Value to EBIT (EV/EBIT)
14.82 14.83 12.36 19.76 18.41 16.96 15.06 17.27 15.55 20.40
Enterprise Value to NOPAT (EV/NOPAT)
20.31 20.13 16.84 26.71 25.04 23.16 19.46 21.56 25.19 34.84
Enterprise Value to Operating Cash Flow (EV/OCF)
11.28 11.82 16.45 35.79 12.19 14.96 13.63 19.76 14.80 25.03
Enterprise Value to Free Cash Flow (EV/FCFF)
12.20 13.07 0.00 0.00 11.64 36.12 0.00 29.33 19.50 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.58 0.55 0.56 0.55 0.65 0.75 0.93 0.58 0.74 0.96
Long-Term Debt to Equity
0.58 0.55 0.56 0.55 0.65 0.75 0.93 0.58 0.74 0.96
Financial Leverage
0.46 0.49 0.40 0.29 0.48 0.78 0.73 0.62 0.81 0.73
Leverage Ratio
1.90 1.88 1.88 1.96 2.10 2.20 2.07 1.92 2.13 2.13
Compound Leverage Factor
1.50 1.54 1.67 1.75 1.80 1.63 1.62 1.68 1.77 1.70
Debt to Total Capital
36.78% 35.39% 35.94% 35.66% 39.44% 42.86% 48.21% 36.72% 42.43% 49.05%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
36.78% 35.39% 35.94% 35.66% 39.44% 42.86% 48.21% 36.72% 42.43% 49.05%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
63.22% 64.61% 64.06% 64.34% 60.56% 57.14% 51.79% 63.28% 57.57% 50.95%
Debt to EBITDA
2.58 2.23 2.13 2.35 2.79 2.81 3.10 2.03 2.54 3.71
Net Debt to EBITDA
2.07 1.85 1.99 1.14 2.05 2.55 2.98 1.90 2.43 3.59
Long-Term Debt to EBITDA
2.58 2.23 2.13 2.35 2.79 2.81 3.10 2.03 2.54 3.71
Debt to NOPAT
4.65 3.86 3.55 3.98 5.00 5.10 5.47 3.20 5.47 8.48
Net Debt to NOPAT
3.73 3.21 3.31 1.94 3.67 4.63 5.26 2.99 5.23 8.21
Long-Term Debt to NOPAT
4.65 3.86 3.55 3.98 5.00 5.10 5.47 3.20 5.47 8.48
Altman Z-Score
3.47 3.91 3.75 4.59 3.53 3.45 3.20 4.86 3.78 3.27
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
2.50 2.47 2.22 2.90 2.39 2.32 2.23 3.00 2.69 2.58
Quick Ratio
2.33 2.33 2.09 2.75 2.11 2.18 2.13 2.79 2.38 2.36
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
370 413 -227 -35 445 130 -509 132 151 -492
Operating Cash Flow to CapEx
1,133.14% 1,145.11% 820.80% 558.21% 1,303.07% 957.80% 1,001.39% 808.23% 734.51% 502.43%
Free Cash Flow to Firm to Interest Expense
5.75 6.22 -4.95 -0.93 11.20 1.81 -9.10 4.79 4.68 -16.30
Operating Cash Flow to Interest Expense
6.22 6.88 6.71 5.17 10.70 4.36 5.13 7.12 6.17 4.11
Operating Cash Flow Less CapEx to Interest Expense
5.67 6.28 5.89 4.24 9.88 3.91 4.62 6.24 5.33 3.29
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
1.18 1.25 1.29 1.18 1.13 1.21 1.51 1.47 1.39 1.37
Accounts Receivable Turnover
5.89 5.58 5.87 6.12 5.60 5.41 6.52 6.44 6.58 6.54
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
50.00 60.27 75.53 72.97 54.47 44.71 49.60 45.69 44.32 42.36
Accounts Payable Turnover
95.29 91.64 116.15 98.19 65.93 59.39 95.10 270.39 213.69 162.54
Days Sales Outstanding (DSO)
61.98 65.41 62.22 59.67 65.22 67.46 55.95 56.67 55.46 55.85
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
3.83 3.98 3.14 3.72 5.54 6.15 3.84 1.35 1.71 2.25
Cash Conversion Cycle (CCC)
58.15 61.43 59.08 55.96 59.68 61.31 52.11 55.32 53.76 53.60
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
2,605 2,753 2,898 2,370 2,075 2,313 2,241 1,530 1,482 1,516
Invested Capital Turnover
1.53 1.58 1.74 1.80 1.60 1.50 1.80 1.74 1.63 1.68
Increase / (Decrease) in Invested Capital
-148 -145 528 294 -238 73 711 48 -34 581
Enterprise Value (EV)
4,512 5,400 5,062 6,933 5,178 4,684 3,919 3,882 2,951 3,105
Market Capitalization
3,684 4,539 4,066 6,429 4,419 3,747 2,860 3,343 2,338 2,373
Book Value per Share
$40.20 $40.09 $38.10 $35.80 $30.00 $26.06 $22.53 $19.06 $16.41 $14.86
Tangible Book Value per Share
($12.58) ($10.59) ($11.23) ($3.69) ($5.74) ($11.12) ($13.87) ($4.91) ($7.22) ($9.62)
Total Capital
2,810 2,929 2,968 2,899 2,621 2,409 2,283 1,567 1,509 1,540
Total Debt
1,034 1,037 1,067 1,034 1,033 1,032 1,100 575 640 756
Total Long-Term Debt
1,034 1,037 1,067 1,034 1,033 1,032 1,100 575 640 756
Net Debt
828 861 996 504 759 937 1,059 539 613 732
Capital Expenditures (CapEx)
35 40 38 35 33 33 29 24 27 25
Debt-free, Cash-free Net Working Capital (DFCFNWC)
345 403 469 329 304 355 336 296 248 230
Debt-free Net Working Capital (DFNWC)
551 579 539 859 578 451 378 333 275 254
Net Working Capital (NWC)
551 579 539 859 578 451 378 333 275 254
Net Nonoperating Expense (NNE)
47 49 32 -150 6.50 28 44 22 20 -8.54
Net Nonoperating Obligations (NNO)
828 861 996 504 488 937 1,059 539 613 732
Total Depreciation and Amortization (D&A)
96 100 91 90 90 91 95 59 62 52
Debt-free, Cash-free Net Working Capital to Revenue
8.43% 9.06% 10.24% 8.20% 8.67% 10.41% 9.89% 11.28% 10.16% 11.14%
Debt-free Net Working Capital to Revenue
13.43% 13.01% 11.77% 21.41% 16.51% 13.19% 11.12% 12.67% 11.27% 12.29%
Net Working Capital to Revenue
13.43% 13.01% 11.77% 21.41% 16.51% 13.19% 11.12% 12.67% 11.27% 12.29%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$3.88 $4.54 $5.30 $7.78 $3.80 $3.31 $3.02 $6.02 $3.66 $3.74
Adjusted Weighted Average Basic Shares Outstanding
45.20M 48.30M 50.60M 52.70M 52.70M 52.80M 52.33M 52.50M 53.19M 52.26M
Adjusted Diluted Earnings per Share
$3.83 $4.50 $5.23 $7.66 $3.76 $3.28 $2.98 $5.94 $3.62 $3.68
Adjusted Weighted Average Diluted Shares Outstanding
45.70M 48.70M 51.30M 53.50M 53.30M 53.40M 53.06M 53.21M 53.75M 53.01M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
43.60M 46.50M 49.30M 51.60M 53M 53M 52.66M 52.18M 52.65M 53.20M
Normalized Net Operating Profit after Tax (NOPAT)
222 268 301 260 207 202 201 180 117 89
Normalized NOPAT Margin
5.42% 6.03% 6.56% 6.47% 5.90% 5.92% 5.92% 6.85% 4.80% 4.32%
Pre Tax Income Margin
5.86% 6.69% 7.94% 7.82% 6.90% 5.98% 6.01% 7.51% 6.45% 5.90%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
4.73 5.48 8.92 9.36 7.08 3.85 4.65 8.14 5.87 5.04
NOPAT to Interest Expense
3.45 4.04 6.55 6.92 5.21 2.82 3.60 6.52 3.62 2.95
EBIT Less CapEx to Interest Expense
4.19 4.88 8.10 8.43 6.26 3.39 4.13 7.26 5.03 4.22
NOPAT Less CapEx to Interest Expense
2.91 3.44 5.73 6.00 4.39 2.36 3.08 5.64 2.78 2.13
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 17.30% 0.00%
Augmented Payout Ratio
186.76% 124.53% 104.96% 44.23% 13.93% 11.45% 0.00% 38.11% 59.58% 1.68%

Quarterly Metrics And Ratios for ASGN

This table displays calculated financial ratios and metrics derived from ASGN's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-7.69% -8.30% -7.68% -8.51% -7.07% -6.63% -6.77% -0.95% 3.46% 9.17% 11.56%
EBITDA Growth
-24.32% -10.08% -17.10% -14.58% -12.56% -6.75% -7.50% -5.39% -9.61% -0.51% 7.41%
EBIT Growth
-34.27% -11.03% -19.98% -17.88% -15.80% -7.74% -9.04% -11.08% -16.30% -5.34% 8.29%
NOPAT Growth
-38.41% -15.65% -18.51% -18.03% -16.34% -4.90% -8.64% -10.34% -18.67% -8.72% 9.14%
Net Income Growth
-45.14% -15.71% -20.03% -21.46% -23.03% -9.53% -18.85% -17.10% -25.90% -34.59% -65.47%
EPS Growth
-40.74% -11.32% -13.82% -16.39% -18.18% 411.76% -57.29% -13.48% -22.66% -121.38% -27.46%
Operating Cash Flow Growth
-77.08% -13.92% -7.93% -19.38% -8.94% 54.58% 67.42% 27.26% 43.75% 191.61% 23.74%
Free Cash Flow Firm Growth
-237.32% -3.29% 598.23% 154.47% 147.48% 144.98% 106.37% -78.94% -1,189.96% -108.15% -330.63%
Invested Capital Growth
11.43% -5.37% -5.66% -5.49% -5.34% -5.00% 1.52% 19.52% 20.53% 22.28% 26.05%
Revenue Q/Q Growth
-1.70% -4.46% -0.36% -1.36% -2.34% -3.82% -1.25% 0.19% -1.88% -3.97% 4.91%
EBITDA Q/Q Growth
-26.40% -4.11% -2.48% 9.96% -12.56% -11.59% 0.49% 12.56% -6.75% -12.29% 2.77%
EBIT Q/Q Growth
-37.20% -5.96% -1.87% 13.40% -14.99% -15.42% 0.72% 16.27% -6.86% -16.61% -1.54%
NOPAT Q/Q Growth
-41.16% -10.96% 1.43% 15.91% -19.42% -13.98% 2.03% 18.30% -8.40% -17.37% 0.13%
Net Income Q/Q Growth
-50.71% -10.74% 0.64% 23.88% -24.25% -15.32% -1.16% 21.41% -10.97% -24.04% 0.97%
EPS Q/Q Growth
-48.94% -11.32% 3.92% 25.93% 576.47% -13.82% 0.82% 23.23% 391.18% -111.81% 104.26%
Operating Cash Flow Q/Q Growth
-83.23% -26.22% 49.72% 23.74% -37.03% -21.08% 31.11% 39.75% 6.91% -14.53% -0.34%
Free Cash Flow Firm Q/Q Growth
-240.34% -7.86% 0.85% 5.29% -1.16% 565.28% 107.87% 8.21% 6.38% 5.79% -121.03%
Invested Capital Q/Q Growth
17.17% -1.41% -2.54% -1.03% -0.49% -1.71% -2.37% -0.88% -0.13% 5.04% 14.95%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
28.44% 29.04% 29.14% 29.10% 28.24% 28.39% 28.87% 28.85% 28.92% 29.56% 29.96%
EBITDA Margin
7.46% 9.96% 9.92% 10.14% 9.09% 10.16% 11.05% 10.86% 9.67% 10.17% 11.14%
Operating Margin
4.81% 7.53% 7.65% 7.77% 6.76% 7.76% 8.83% 8.66% 7.46% 7.86% 9.05%
EBIT Margin
4.81% 7.53% 7.65% 7.77% 6.76% 7.76% 8.83% 8.66% 7.46% 7.86% 9.05%
Profit (Net Income) Margin
2.16% 4.30% 4.61% 4.56% 3.63% 4.68% 5.32% 5.31% 4.39% 4.83% 6.11%
Tax Burden Percent
66.99% 71.50% 75.52% 73.07% 71.48% 75.41% 74.16% 73.20% 71.95% 73.16% 76.01%
Interest Burden Percent
66.95% 79.92% 79.72% 80.35% 75.18% 79.98% 81.24% 83.86% 81.71% 84.07% 88.84%
Effective Tax Rate
33.01% 28.50% 24.48% 26.94% 28.52% 24.59% 25.84% 26.80% 28.05% 26.84% 26.17%
Return on Invested Capital (ROIC)
4.47% 8.24% 8.90% 8.70% 7.50% 9.22% 10.66% 11.09% 9.36% 10.00% 12.11%
ROIC Less NNEP Spread (ROIC-NNEP)
3.51% 6.98% 7.52% 7.45% 6.14% 7.87% 9.11% 9.53% 7.89% 8.60% 11.00%
Return on Net Nonoperating Assets (RNNOA)
2.05% 3.21% 3.59% 3.68% 3.00% 3.85% 4.22% 3.74% 3.12% 3.42% 3.61%
Return on Equity (ROE)
6.53% 11.46% 12.49% 12.38% 10.49% 13.08% 14.89% 14.83% 12.49% 13.42% 15.73%
Cash Return on Invested Capital (CROIC)
-3.80% 13.81% 14.35% 14.44% 14.66% 14.62% 8.26% -7.21% -7.79% -8.63% -10.64%
Operating Return on Assets (OROA)
5.38% 8.86% 9.15% 9.47% 8.42% 9.69% 11.12% 11.26% 9.82% 10.16% 11.21%
Return on Assets (ROA)
2.41% 5.06% 5.51% 5.56% 4.53% 5.85% 6.70% 6.91% 5.77% 6.25% 7.57%
Return on Common Equity (ROCE)
6.53% 11.46% 12.49% 12.38% 10.49% 13.08% 14.89% 14.83% 12.49% 13.42% 15.73%
Return on Equity Simple (ROE_SIMPLE)
8.81% 0.00% 10.32% 10.79% 11.17% 0.00% 11.77% 12.37% 13.04% 0.00% 15.75%
Net Operating Profit after Tax (NOPAT)
31 53 60 59 51 63 73 72 61 66 80
NOPAT Margin
3.22% 5.39% 5.78% 5.68% 4.83% 5.86% 6.55% 6.34% 5.37% 5.75% 6.68%
Net Nonoperating Expense Percent (NNEP)
0.97% 1.26% 1.37% 1.25% 1.36% 1.36% 1.56% 1.56% 1.48% 1.40% 1.12%
Return On Investment Capital (ROIC_SIMPLE)
1.00% 1.89% - - - 2.15% - - - 2.23% -
Cost of Revenue to Revenue
71.56% 70.96% 70.86% 70.90% 71.76% 71.61% 71.13% 71.15% 71.08% 70.44% 70.04%
SG&A Expenses to Revenue
22.15% 20.09% 20.13% 19.87% 20.04% 18.96% 18.45% 18.61% 19.85% 19.98% 19.42%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
23.63% 21.50% 21.48% 21.33% 21.48% 20.62% 20.04% 20.20% 21.46% 21.71% 20.91%
Earnings before Interest and Taxes (EBIT)
47 74 79 80 71 83 99 98 84 90 108
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
72 98 102 105 95 109 123 123 109 117 133
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.53 2.07 2.35 2.24 2.66 2.40 2.07 1.94 2.12 2.14 2.40
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.68 0.90 1.00 0.95 1.13 1.02 0.87 0.81 0.88 0.89 1.01
Price to Earnings (P/E)
17.84 21.64 22.36 20.52 23.61 20.45 17.53 15.64 16.34 15.30 15.36
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.60% 4.62% 4.47% 4.87% 4.23% 4.89% 5.70% 6.39% 6.12% 6.53% 6.51%
Enterprise Value to Invested Capital (EV/IC)
1.30 1.73 1.91 1.83 2.13 1.96 1.73 1.63 1.74 1.75 1.96
Enterprise Value to Revenue (EV/Rev)
0.99 1.10 1.20 1.16 1.33 1.21 1.07 1.01 1.09 1.11 1.21
Enterprise Value to EBITDA (EV/EBITDA)
10.51 11.26 12.25 11.44 12.92 11.63 10.26 9.68 10.31 10.11 10.78
Enterprise Value to EBIT (EV/EBIT)
14.17 14.82 16.09 14.85 16.60 14.83 13.06 12.26 12.84 12.36 13.04
Enterprise Value to NOPAT (EV/NOPAT)
19.55 20.31 21.74 20.16 22.53 20.13 17.85 16.77 17.60 16.84 17.62
Enterprise Value to Operating Cash Flow (EV/OCF)
11.55 11.28 12.12 11.57 12.95 11.82 11.65 13.10 15.19 16.45 35.97
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 12.20 12.92 12.29 14.10 13.07 21.10 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.74 0.58 0.58 0.57 0.56 0.55 0.54 0.54 0.54 0.56 0.57
Long-Term Debt to Equity
0.74 0.58 0.58 0.57 0.56 0.55 0.54 0.54 0.54 0.56 0.57
Financial Leverage
0.58 0.46 0.48 0.49 0.49 0.49 0.46 0.39 0.40 0.40 0.33
Leverage Ratio
1.97 1.90 1.90 1.88 1.85 1.88 1.89 1.87 1.85 1.88 1.94
Compound Leverage Factor
1.32 1.52 1.52 1.51 1.39 1.50 1.54 1.57 1.51 1.58 1.73
Debt to Total Capital
42.53% 36.78% 36.83% 36.42% 35.76% 35.39% 35.21% 34.96% 34.99% 35.94% 36.39%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
42.53% 36.78% 36.83% 36.42% 35.76% 35.39% 35.21% 34.96% 34.99% 35.94% 36.39%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
57.47% 63.22% 63.17% 63.58% 64.24% 64.61% 64.79% 65.04% 65.01% 64.06% 63.61%
Debt to EBITDA
3.52 2.58 2.51 2.39 2.30 2.23 2.20 2.15 2.12 2.13 2.16
Net Debt to EBITDA
3.23 2.07 2.11 2.09 1.95 1.85 1.89 1.95 1.98 1.99 1.73
Long-Term Debt to EBITDA
3.52 2.58 2.51 2.39 2.30 2.23 2.20 2.15 2.12 2.13 2.16
Debt to NOPAT
6.54 4.65 4.46 4.22 4.01 3.86 3.82 3.72 3.61 3.55 3.52
Net Debt to NOPAT
6.01 3.73 3.74 3.68 3.40 3.21 3.29 3.38 3.38 3.31 2.83
Long-Term Debt to NOPAT
6.54 4.65 4.46 4.22 4.01 3.86 3.82 3.72 3.61 3.55 3.52
Altman Z-Score
2.57 3.25 3.43 3.43 3.80 3.65 3.43 3.42 3.58 3.46 3.59
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.37 2.50 2.25 2.34 2.51 2.47 2.24 2.33 2.40 2.22 2.28
Quick Ratio
2.19 2.33 2.11 2.19 2.38 2.33 2.14 2.21 2.30 2.09 2.21
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-282 201 218 216 205 208 31 -397 -432 -462 -490
Operating Cash Flow to CapEx
164.71% 886.73% 1,718.99% 1,711.32% 678.70% 1,616.67% 1,505.10% 1,004.46% 688.03% 717.14% 1,024.42%
Free Cash Flow to Firm to Interest Expense
-18.30 13.48 13.62 13.68 11.66 12.44 1.69 -25.12 -28.07 -32.07 -40.51
Operating Cash Flow to Interest Expense
1.09 6.72 8.49 5.74 4.16 6.97 7.97 7.12 5.23 5.23 7.28
Operating Cash Flow Less CapEx to Interest Expense
0.43 5.97 7.99 5.41 3.55 6.54 7.44 6.41 4.47 4.50 6.57
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.12 1.18 1.20 1.22 1.25 1.25 1.26 1.30 1.32 1.29 1.24
Accounts Receivable Turnover
5.62 5.89 5.62 5.51 5.65 5.58 5.38 5.51 5.78 5.87 5.69
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
49.43 50.00 53.09 55.09 56.51 60.27 64.26 67.96 70.84 75.53 78.40
Accounts Payable Turnover
113.79 95.29 103.15 129.79 104.21 91.64 97.92 114.06 117.31 116.15 95.92
Days Sales Outstanding (DSO)
64.96 61.98 64.96 66.19 64.64 65.41 67.83 66.22 63.16 62.22 64.12
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
3.21 3.83 3.54 2.81 3.50 3.98 3.73 3.20 3.11 3.14 3.81
Cash Conversion Cycle (CCC)
61.75 58.15 61.42 63.38 61.14 61.43 64.10 63.02 60.05 59.08 60.31
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,052 2,605 2,642 2,711 2,739 2,753 2,801 2,869 2,894 2,898 2,759
Invested Capital Turnover
1.39 1.53 1.54 1.53 1.55 1.58 1.63 1.75 1.74 1.74 1.81
Increase / (Decrease) in Invested Capital
313 -148 -158 -157 -155 -145 42 469 493 528 570
Enterprise Value (EV)
3,968 4,512 5,045 4,950 5,823 5,400 4,845 4,670 5,046 5,062 5,406
Market Capitalization
2,748 3,684 4,177 4,047 4,945 4,539 3,953 3,729 4,076 4,066 4,537
Book Value per Share
$41.13 $40.20 $39.61 $39.39 $40.03 $40.09 $39.44 $39.08 $39.02 $38.10 $37.63
Tangible Book Value per Share
($19.51) ($12.58) ($12.80) ($12.06) ($11.09) ($10.59) ($10.34) ($10.16) ($10.58) ($11.23) ($9.21)
Total Capital
3,121 2,810 2,809 2,843 2,898 2,929 2,946 2,962 2,959 2,968 2,970
Total Debt
1,327 1,034 1,034 1,035 1,036 1,037 1,038 1,036 1,035 1,067 1,081
Total Long-Term Debt
1,327 1,034 1,034 1,035 1,036 1,037 1,038 1,036 1,035 1,067 1,081
Net Debt
1,220 828 868 903 878 861 892 942 970 996 870
Capital Expenditures (CapEx)
10 11 7.90 5.30 11 7.20 9.80 11 12 11 8.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)
401 345 337 392 403 403 405 462 476 469 417
Debt-free Net Working Capital (DFNWC)
508 551 504 524 562 579 551 556 541 539 628
Net Working Capital (NWC)
508 551 504 524 562 579 551 556 541 539 628
Net Nonoperating Expense (NNE)
10 11 12 12 13 13 14 12 11 11 6.83
Net Nonoperating Obligations (NNO)
1,259 828 868 903 878 861 892 942 970 996 870
Total Depreciation and Amortization (D&A)
26 24 23 25 25 26 25 25 25 27 25
Debt-free, Cash-free Net Working Capital to Revenue
9.98% 8.43% 8.05% 9.16% 9.23% 9.06% 8.95% 10.02% 10.30% 10.24% 9.29%
Debt-free Net Working Capital to Revenue
12.64% 13.43% 12.02% 12.25% 12.85% 13.01% 12.17% 12.06% 11.71% 11.77% 14.00%
Net Working Capital to Revenue
12.64% 13.43% 12.02% 12.25% 12.85% 13.01% 12.17% 12.06% 11.71% 11.77% 14.00%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.48 $0.96 $1.07 $1.03 $0.82 $1.08 $2.46 $1.23 $1.00 ($0.34) $1.46
Adjusted Weighted Average Basic Shares Outstanding
43.70M 45.20M 44.50M 45.70M 46.50M 48.30M 48.10M 49M 49.30M 50.60M 50.10M
Adjusted Diluted Earnings per Share
$0.48 $0.94 $1.06 $1.02 $0.81 $1.06 $2.46 $1.22 $0.99 ($0.34) $1.44
Adjusted Weighted Average Diluted Shares Outstanding
44M 45.70M 45M 46.10M 46.90M 48.70M 48.40M 49.20M 49.80M 51.30M 50.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
43.80M 43.60M 44.20M 44.80M 45.90M 46.50M 47.20M 48.40M 49.30M 49.30M 49.90M
Normalized Net Operating Profit after Tax (NOPAT)
31 53 60 59 51 63 73 72 61 66 80
Normalized NOPAT Margin
3.22% 5.39% 5.78% 5.68% 4.83% 5.86% 6.55% 6.34% 5.37% 5.75% 6.68%
Pre Tax Income Margin
3.22% 6.02% 6.10% 6.24% 5.08% 6.21% 7.17% 7.26% 6.10% 6.61% 8.04%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.03 4.98 4.93 5.09 4.03 4.99 5.33 6.20 5.47 6.28 8.96
NOPAT to Interest Expense
2.03 3.56 3.72 3.72 2.88 3.77 3.95 4.54 3.93 4.59 6.61
EBIT Less CapEx to Interest Expense
2.36 4.22 4.44 4.75 3.41 4.56 4.80 5.49 4.71 5.55 8.25
NOPAT Less CapEx to Interest Expense
1.36 2.80 3.23 3.38 2.27 3.34 3.42 3.83 3.17 3.86 5.90
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
188.54% 186.76% 195.90% 181.74% 146.22% 124.53% 111.98% 92.16% 101.00% 104.96% 97.65%

Frequently Asked Questions About ASGN's Financials

When does ASGN's financial year end?

According to the most recent income statement we have on file, ASGN's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has ASGN's net income changed over the last 9 years?

ASGN's net income appears to be on an upward trend, with a most recent value of $175.20 million in 2024, rising from $97.65 million in 2015. The previous period was $219.30 million in 2023. See ASGN's forecast for analyst expectations on what’s next for the company.

What is ASGN's operating income?
ASGN's total operating income in 2024 was $304.40 million, based on the following breakdown:
  • Total Gross Profit: $1.18 billion
  • Total Operating Expenses: $879.30 million
How has ASGN revenue changed over the last 9 years?

Over the last 9 years, ASGN's total revenue changed from $2.07 billion in 2015 to $4.10 billion in 2024, a change of 98.5%.

How much debt does ASGN have?

ASGN's total liabilities were at $1.65 billion at the end of 2024, a 0.0% decrease from 2023, and a 68.2% increase since 2015.

How much cash does ASGN have?

In the past 9 years, ASGN's cash and equivalents has ranged from $0.00 in 2016 to $529.60 million in 2021, and is currently $205.20 million as of their latest financial filing in 2024.

How has ASGN's book value per share changed over the last 9 years?

Over the last 9 years, ASGN's book value per share changed from 14.86 in 2015 to 40.20 in 2024, a change of 170.4%.



This page (NYSE:ASGN) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners